Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 11:09:49 UTC |
---|
Update Date | 2021-09-26 23:05:57 UTC |
---|
HMDB ID | HMDB0252997 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine |
---|
Description | Gyki-52466 belongs to the class of organic compounds known as benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms). Gyki-52466 is a strong basic compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). 4-(8-methyl-9h-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1=NN=C(C2=CC=C(N)C=C2)C2=CC3=C(OCO3)C=C2C1 InChI=1S/C17H15N3O2/c1-10-6-12-7-15-16(22-9-21-15)8-14(12)17(20-19-10)11-2-4-13(18)5-3-11/h2-5,7-8H,6,9,18H2,1H3 |
---|
Synonyms | Value | Source |
---|
4-(8-Methyl-9H-1,3-dioxolo[4,5-H][2,3]benzodiazepin-5-yl)benzenamine | Kegg | 1-(p-Aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride | MeSH |
|
---|
Chemical Formula | C17H15N3O2 |
---|
Average Molecular Weight | 293.326 |
---|
Monoisotopic Molecular Weight | 293.116426735 |
---|
IUPAC Name | 4-{13-methyl-4,6-dioxa-11,12-diazatricyclo[7.5.0.0³,⁷]tetradeca-1,3(7),8,10,12-pentaen-10-yl}aniline |
---|
Traditional Name | 4-{13-methyl-4,6-dioxa-11,12-diazatricyclo[7.5.0.0³,⁷]tetradeca-1,3(7),8,10,12-pentaen-10-yl}aniline |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=NN=C(C2=CC=C(N)C=C2)C2=CC3=C(OCO3)C=C2C1 |
---|
InChI Identifier | InChI=1S/C17H15N3O2/c1-10-6-12-7-15-16(22-9-21-15)8-14(12)17(20-19-10)11-2-4-13(18)5-3-11/h2-5,7-8H,6,9,18H2,1H3 |
---|
InChI Key | LFBZZHVSGAHQPP-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - Benzodiazepine
- Benzodioxole
- Aniline or substituted anilines
- Monocyclic benzene moiety
- Benzenoid
- Acetal
- Oxacycle
- Azacycle
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,1TMS,isomer #1 | CC1=NN=C(C2=CC=C(N[Si](C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 3108.7 | Semi standard non polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,1TMS,isomer #1 | CC1=NN=C(C2=CC=C(N[Si](C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 2776.9 | Standard non polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,1TMS,isomer #1 | CC1=NN=C(C2=CC=C(N[Si](C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 4358.6 | Standard polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,2TMS,isomer #1 | CC1=NN=C(C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 3049.4 | Semi standard non polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,2TMS,isomer #1 | CC1=NN=C(C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 2874.9 | Standard non polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,2TMS,isomer #1 | CC1=NN=C(C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 4351.6 | Standard polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,1TBDMS,isomer #1 | CC1=NN=C(C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 3301.8 | Semi standard non polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,1TBDMS,isomer #1 | CC1=NN=C(C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 2987.5 | Standard non polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,1TBDMS,isomer #1 | CC1=NN=C(C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 4458.7 | Standard polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,2TBDMS,isomer #1 | CC1=NN=C(C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 3379.3 | Semi standard non polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,2TBDMS,isomer #1 | CC1=NN=C(C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 3303.1 | Standard non polar | 33892256 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine,2TBDMS,isomer #1 | CC1=NN=C(C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C2=CC3=C(C=C2C1)OCO3 | 4486.1 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fb9-0290000000-1a3a4dab5619b7e5e917 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine 10V, Negative-QTOF | splash10-0006-0090000000-c7b26c91f7086b4cc21f | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine 20V, Negative-QTOF | splash10-0006-0090000000-44e5993c0ac93feb6e8f | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine 40V, Negative-QTOF | splash10-03dl-0090000000-da947b32e62f3ce06210 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine 10V, Positive-QTOF | splash10-0006-0090000000-ce7dac974a90f440783e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine 20V, Positive-QTOF | splash10-0006-0090000000-340b9025169635b686bd | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine 40V, Positive-QTOF | splash10-0f9i-0190000000-c9ddffc41671807baee2 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|